WO2007069033A3 - Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol - Google Patents

Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol Download PDF

Info

Publication number
WO2007069033A3
WO2007069033A3 PCT/IB2006/003567 IB2006003567W WO2007069033A3 WO 2007069033 A3 WO2007069033 A3 WO 2007069033A3 IB 2006003567 W IB2006003567 W IB 2006003567W WO 2007069033 A3 WO2007069033 A3 WO 2007069033A3
Authority
WO
WIPO (PCT)
Prior art keywords
dexibuprofen
paracetamol
pharmaceutically acceptable
opiate
pharmaceutical compositions
Prior art date
Application number
PCT/IB2006/003567
Other languages
French (fr)
Other versions
WO2007069033A2 (en
Inventor
Bradley Ryan Parsons
Original Assignee
Adcock Ingram Ltd
Bradley Ryan Parsons
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Ltd, Bradley Ryan Parsons filed Critical Adcock Ingram Ltd
Publication of WO2007069033A2 publication Critical patent/WO2007069033A2/en
Publication of WO2007069033A3 publication Critical patent/WO2007069033A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition including a combination of a sub-therapeutic amount of the S isomer of ibuprofen, also referred to as dexibuprofen, or a pharmaceutically acceptable salt or derivative thereof, an opiate or a pharmaceutically acceptable salt or derivative thereof, and a centrally-acting cyclo-oxygenase inhibitor, as active ingredients, and a pharmaceutically acceptable carrier. A typical combination includes paracetamol, dexibuprofen and codeine, with the dexibuprofen being provided in an amount to give a daily dose of 100 mg or less. A method of treatment using a combination of a sub-therapeutic amount of dexibuprofen, an opiate and a centrally-acting cyclo-oxygenase inhibitor is also described.
PCT/IB2006/003567 2005-12-12 2006-12-12 Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol WO2007069033A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA2005/10091 2005-12-12
ZA200510091 2005-12-12

Publications (2)

Publication Number Publication Date
WO2007069033A2 WO2007069033A2 (en) 2007-06-21
WO2007069033A3 true WO2007069033A3 (en) 2007-10-04

Family

ID=38055508

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/003567 WO2007069033A2 (en) 2005-12-12 2006-12-12 Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol

Country Status (2)

Country Link
WO (1) WO2007069033A2 (en)
ZA (1) ZA200803566B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2711211A1 (en) * 2008-01-03 2009-07-09 Aft Pharmaceuticals Ltd. Oral pharmaceutical suspension comprising paracetamol and ibuprofen
GB201811858D0 (en) * 2018-07-20 2018-09-05 Wockhardt Uk Ltd Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
WO1996005834A1 (en) * 1994-08-23 1996-02-29 Smithkline Beecham Plc Improved pharmaceutical formulations containing ibuprofen and codeine
WO2006004449A2 (en) * 2004-07-07 2006-01-12 Aft Pharmaceuticals Limited A combination composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
WO1996005834A1 (en) * 1994-08-23 1996-02-29 Smithkline Beecham Plc Improved pharmaceutical formulations containing ibuprofen and codeine
WO2006004449A2 (en) * 2004-07-07 2006-01-12 Aft Pharmaceuticals Limited A combination composition

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BEUBLER E: "Clinical pharmacology of analgesics: outlook and risks", DER INTERNIST ; ORGAN DES BERUFSVERBANDES DEUTSCHER INTERNISTEN ORGAN DER DEUTSCHEN GESELLSCHAFT FÜR INNERE MEDIZIN, SPRINGER-VERLAG, BE, vol. 46, no. 10, 1 October 2005 (2005-10-01), pages 1076 - 1086, XP019320006, ISSN: 1432-1289 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 17 October 1987 (1987-10-17), VLOK G J ET AL: "Comparison of a standard ibuprofen treatment regimen with a new ibuprofen/paracetamol/codeine combination in chronic osteo-arthritis.", XP002440673, Database accession no. NLM3313757 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; September 1992 (1992-09-01), LOWNIE J F ET AL: "Comparison of the safety and efficacy of a combination analgesic Myprodol and Ponstan in the treatment of dental pain.", XP002440674, Database accession no. NLM9511622 *
SOUTH AFRICAN MEDICAL JOURNAL = SUID-AFRIKAANSE TYDSKRIF VIR GENEESKUNDE 17 OCT 1987, vol. Suppl, 17 October 1987 (1987-10-17), pages 1 , 4 - 6, ISSN: 0256-9574 *
THE JOURNAL OF THE DENTAL ASSOCIATION OF SOUTH AFRICA = DIE TYDSKRIF VAN DIE TANDHEELKUNDIGE VERENIGING VAN SUID-AFRIKA SEP 1992, vol. 47, no. 9, September 1992 (1992-09-01), pages 403 - 406, ISSN: 0011-8516 *
WARD ET AL: "Paracetamol revisited: A review of the pharmacokinetics and pharmacodynamics", ACUTE PAIN, ELSEVIER, vol. 2, no. 3, September 1999 (1999-09-01), pages 139 - 149, XP005162523, ISSN: 1366-0071 *

Also Published As

Publication number Publication date
ZA200803566B (en) 2009-10-28
WO2007069033A2 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
MX2009004203A (en) Acetaminophen / ibuprofen combinations.
WO2006004449A3 (en) A combination composition
WO2005032567A3 (en) Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium
WO2008064192A3 (en) Modified release analgesic suspensions
EP1283054A4 (en) Drugs for complications of diabetes and neuropathy and utilization thereof
WO2008027350A3 (en) Acetaminophen pharmaceutical compositions
MX2009013574A (en) Modified release solid or semi-solid dosage forms.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
WO2001013909A3 (en) Compositions and methods for treating opiate intolerance
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
WO2007056264A3 (en) Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
GB2456475A (en) Composition for the treatment of skin conditions
CA2595363A1 (en) Methods and materials with trans-clomiphene for the treatment of male infertility
WO2005092442B1 (en) Method and compositions for treatment of chronic neuropathic pain
WO2004105690A3 (en) Treatment of chronic pain associated with drug or radiation therapy
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
CA2476939A1 (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
WO2007069033A3 (en) Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
AR036321A1 (en) METHOD AND PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF LATE APPEARANCE DYSCINESIA.
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
JP2009526833A5 (en)
GEP20043231B (en) Resorcinol Composition
MX2008015323A (en) Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association.

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06831689

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06831689

Country of ref document: EP

Kind code of ref document: A2